Categories AlphaGraphs, Earnings, Health Care
Medtronic beats Q3 estimates and raises full-year guidance
Medtronic plc (MDT) topped consensus estimates on revenue and earnings for the third quarter of 2019 and raised its earnings guidance for fiscal year 2019. Shares were up 0.79% in premarket hours on Tuesday.
Worldwide revenues totaled $7.5 billion, up 2.4% from the same period last year. On an organic basis, revenues grew 4.4%.
On a GAAP basis, the company reported a net income of $1.26 billion, or $0.94 per share, compared to a net loss of $1.38 billion, or $1.03 per share, in the year-ago quarter. Adjusted net income rose 10% to $1.75 billion, or $1.29 per share.
US revenue, which made up 53% of company revenue, grew 2.3% on a reported basis during the quarter. Non-US developed market revenue grew 0.6% on a reported basis and 3.6% on a constant currency basis. Emerging market revenue rose 6.8% on a reported basis and 13.9% on a constant currency basis.
During the quarter, revenues in the Cardiac and Vascular Group (CVG) dropped 0.5% on a reported basis. On a constant currency basis, revenue grew 1.6%, driven by mid-single digit growth in the Aortic, Peripheral & Venous and Coronary & Structural Heart divisions, offset by low single-digit declines in the Cardiac Rhythm & Heart Failure segment.
Also see: Medtronic Q3 2019 Earnings Conference Call Transcript
In the Minimally Invasive Therapies Group, revenues grew 4.1% as reported and 6.6% on a constant currency basis, driven by strong performance in all divisions. In the Restorative Therapies Group, revenues rose 4.2% as reported and 5.5% on a constant currency basis, driven by growth in all business units, except Spine. Revenues in the Diabetes Group increased 4.5% as reported and 6.5% in constant currency.
For fiscal year 2019, Medtronic expects organic revenue to grow 5.25% to 5.5% versus the prior outlook of 5% to 5.5%. The company raised its adjusted EPS guidance to a range of $5.14 to $5.16 from the previous range of $5.10 to $5.15. The outlook for free cash flow was also raised to a range of $5 billion to $5.2 billion from the previous range of $4.7 billion to $5.1 billion.
Get access to timely and accurate verbatim transcripts that are published within hours of the event.
Most Popular
What to look for when CVS Health (CVS) reports Q3 earnings
Healthcare company CVS Health Corporation (NYSE: CVS) is all set to report earnings next week, with Wall Street expecting a mixed outcome. The company has been facing challenges in certain
eBay (EBAY): A few factors that helped drive growth in Q3 2024
Shares of eBay Inc. (NASDAQ: EBAY) stayed green on Friday. The stock has gained 32% year-to-date. The ecommerce leader delivered revenue and earnings growth for the third quarter of 2024,
CVX Earnings: Chevron reports lower revenue and profit for Q3 2024
Energy exploration company Chevron Corporation (NYSE: CVX) on Friday announced third-quarter 2024 financial results, reporting a decline in net profit and revenues. Net income attributable to Chevron Corporation dropped to